Examine This Report on pentobarbital drug
Examine This Report on pentobarbital drug
Blog Article
pentobarbital will reduce the extent or effect of diazepam intranasal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on. Potent or moderate CYP3A4 inducers could increase fee of diazepam elimination; as a result, efficacy of diazepam may be lowered.
pentobarbital will minimize the level or outcome of estrogens esterified by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
pentobarbital will lessen the extent or influence of lorlatinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will raise the level or influence of ivosidenib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Coadministration of ivosidenib with solid CYP3A4 inducers reduced ivosidenib plasma concentrations.
Comment: Barbiturates may well maximize adverse effects, such as respiratory depression, produced by toxic doses of TCAs. With therapeutic doses of TCAs, barbiturates improve metabolism and decrease blood concentrations of TCAs.
pentobarbital will lessen the level or outcome of apremilast by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Coadministration with powerful CYP inducers brings about a major decrease of systemic exposure of apremilast, which can result in lack of efficacy
Monoamine oxidase inhibitors (MAOI) might inhibit barbiturate metabolism and prolong barbiturate effects; monitor intently
pentobarbital will reduce the level or result of parecoxib by influencing hepatic enzyme CYP2C9/10 metabolism. Use Warning/Monitor.
Contraindicated (one)pentobarbital will reduce the extent or effect of doravirine by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will minimize the level or result of cevimeline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Mysterious.
pentobarbital will lessen the extent or impact of vincristine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unknown.
pentobarbital will lessen the level or influence of fruquintinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. If coadministration with reasonable CYP3A4 inducers is unavoidable, go on to administer fruquintinib at here advised dosage.
pentobarbital will lower the extent or influence of pioglitazone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unidentified.
pentobarbital will lower the level or result of tofacitinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check. Lack of, or lessened response to tofacitinib may possibly occur when coadministered with potent CYP3A4 inducers